CG
ZBIO

Cutler Group’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History

Cutler Group’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-399
Closed -$5K – 5008
2019
Q2 		$5K Buy
+399
New +$5.98K ﹤0.01% 3164
2018
Q3 		– Sell
-263
Closed -$4K – 4998
2018
Q2 		$4K Buy
+263
New +$5.3K ﹤0.01% 3315
2018
Q1 		– Sell
-400
Closed -$7.84K – 5645
2017
Q4 		$9K Hold
400
– – ﹤0.01% 3264
2017
Q3 		$8K Hold
400
– – ﹤0.01% 4049
2017
Q2 		$10K Sell
400
-4
-1% -$129 ﹤0.01% 4212
2017
Q1 		$13K Buy
404
+4
+1% +$147 ﹤0.01% 3820
2016
Q4 		$19K Hold
400
– – ﹤0.01% 3536
2016
Q3 		$16K Sell
400
-50
-11% -$2.31K ﹤0.01% 3688
2016
Q2 		$29K Sell
450
-500
-53% -$30.8K ﹤0.01% 2985
2016
Q1 		$68K Sell
950
-5,350
-85% -$396K ﹤0.01% 2004
2015
Q4 		$258K Buy
+6,300
New +$310K 0.01% 983

Other funds holding ZBIO

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutler Group's ZBIO Position: Q3 2019 in Review

Cutler Group sold out of ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) in Q3 2019, closing a stake of 399 shares — an estimated $5K sold.

Cutler Group first reported a position in ZBIO in Q4 2015 and held it in 11 quarters. The position peaked at $258K in Q4 2015. 5 funds tracked by Wall St. Rank hold ZBIO as of Q3 2019.

  • Cutler Group reported no remaining ProShares UltraPro Short NASDAQ Biotechnology position as of Q3 2019 after selling out during the quarter.
  • Cutler Group sold 399 ProShares UltraPro Short NASDAQ Biotechnology shares in Q3 2019, an estimated $5K.
  • Cutler Group first reported a position in ProShares UltraPro Short NASDAQ Biotechnology in Q4 2015 and held it in 11 quarters.
  • Cutler Group's ProShares UltraPro Short NASDAQ Biotechnology position peaked at $258K in Q4 2015.
  • 5 funds tracked by Wall St. Rank held ProShares UltraPro Short NASDAQ Biotechnology as of Q3 2019.

Based on Cutler Group's 13F filing for Q3 2019, filed 28 Oct 2019.